Common questions about our human antibody isotyping Luminex multiplex panel service.
Why does this panel measure IgG subclasses separately instead of just total IgG?
Total IgG measurement (by nephelometry or summation) provides aggregate information but misses clinically and functionally significant subclass-level abnormalities. Selective IgG2 deficiency can present with recurrent infections despite normal total IgG. IgG4 elevation is diagnostic for IgG4-related disease. IgG3 deficiency impairs complement-mediated clearance despite normal IgG1 levels. The 7-plex panel resolves all four subclasses, providing subclass-level data that total IgG measurement alone cannot deliver.
Why is such a high dilution (1:10,000–1:20,000) required for serum samples?
Immunoglobulins circulate at mg/mL concentrations — approximately 1,000,000-fold higher than cytokines (pg/mL). The Luminex assay's dynamic range spans 3–4 logs (e.g., 0.01–100 ng/mL in the assay well). To bring serum IgG from ~10 mg/mL into this range, a 1:10,000 to 1:20,000 dilution is required. This is a standard feature of immunoglobulin assays, not a limitation — the high dilution also minimizes matrix effects that can interfere with immunoassay performance.
Can this panel accurately measure IgE given its extremely low serum concentration?
IgE is present at ~0.00005 mg/mL (50 ng/mL) in normal serum — approximately 200,000-fold lower than IgG. At the standard 1:20,000 serum dilution for IgG measurement, IgE concentrations in the assay well fall below the lower limit of quantitation for most samples. If accurate IgE quantitation is a priority for your study, we can run the assay at two dilution factors: the standard 1:20,000 for IgG subclasses/IgA/IgM and a lower dilution (1:100–1:500) for IgE. Alternatively, we can use a high-sensitivity IgE-specific assay configuration. Contact us to discuss your IgE measurement requirements.
What is the difference between IgG1 and IgG4 for therapeutic antibody development?
IgG1 is the most commonly used backbone for therapeutic antibodies requiring effector functions: it strongly activates complement (C1q binding) and binds all activating Fcγ receptors (FcγRI, FcγRIIa, FcγRIIIa), mediating antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP). IgG4 has minimal complement activation and lower FcγR binding, making it the preferred isotype for blocking antibodies where effector function is undesirable. IgG4 also undergoes Fab-arm exchange in vivo, generating bispecific antibodies — a property relevant to both natural immune responses and therapeutic antibody engineering.
Can this panel be used for hybridoma supernatant screening?
Yes. The 7-plex panel is well-suited for hybridoma screening. Cell culture supernatants typically require lower dilution (1:50–1:200) than serum. The panel identifies productive clones by detecting IgG secretion, determines the subclass (critical for downstream functional characterization), and can identify non-producer clones or clones that have switched to IgM production. For large-scale hybridoma screening campaigns (>100 clones), we can organize plates in screening format and provide rapid turnaround of subclass identity data.
How does this panel detect selective IgG subclass deficiencies?
The panel measures each IgG subclass independently. A selective deficiency is identified when one or more subclasses fall below established age-specific reference ranges while total IgG and other subclasses remain normal. The most common patterns are: isolated IgG2 deficiency (impaired anti-polysaccharide responses), isolated IgG3 deficiency (impaired viral clearance, complement fixation), and combined IgG2/IgG4 deficiency. Because total IgG calculated from the sum of subclasses may still be within normal range, subclass-level measurement is essential for detecting these selective deficiencies.
Can this panel replace serum protein electrophoresis (SPEP) or immunofixation (IFE)?
No. Serum protein electrophoresis (SPEP) and immunofixation (IFE) detect and characterize monoclonal immunoglobulin proteins (M-proteins) based on their electrophoretic mobility. The 7-plex Luminex panel quantifies total immunoglobulin concentrations by isotype and subclass but does not distinguish monoclonal from polyclonal immunoglobulins. For multiple myeloma or plasma cell disorder research, the panel provides complementary quantitative data — total involved isotype concentration, suppression of uninvolved isotypes — but does not replace SPEP/IFE for M-protein identification.
What is the expected variability for IgG subclass measurements?
Intra-assay CV is typically <10% and inter-assay CV <15% across all seven analytes. Note that biological variability between individuals is substantially larger than analytical variability: IgG subclass levels vary 5–10 fold among healthy adults depending on age, sex, and genetic background. For longitudinal studies, each research participant should serve as their own baseline. Age-specific reference ranges should be used when interpreting subclass levels, particularly in pediatric populations where IgG subclass levels increase progressively through childhood.
